NASDAQ:YMAB
Delisted

Y-mabs Therapeutics Stock Signals

etoro logo Buy YMAB
*Your capital is at risk
$8.61
+0 (+0%)
At Close: Dec 15, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Y-mAbs Therapeutics Inc.

General

Signal Type Signal Value Data
Score 0.000 92 days ( -1.06 %
Last Price $8.61 0 %
Performance History
7 Days
$8.61 $8.61
0%
30 Days
$8.61 $8.61
0%
12 Mos
$9.43 $8.61
-8.70%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $8.61 - $8.61
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Dec 12, 2025 - 2 days
RSI Short Pivot Signal Sell Very Low Sep 24, 2025 - 58 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 54.33
Signal Type Signal Value Importance Data
Trend - 12 mos 41.75 % Very High Width: 111.44 %
Pred. range - 12 mos $7.61 - $16.09 High -11.60 % - 86.90 %
Short MA 12 mos Sell Very High Jul 30, 2025 - 97 days
Long MA 12 mos Buy Very High Aug 04, 2025 - 94 days
Short/Long MA 12 mos Buy Very High Aug 04, 2025 - 94 days
Pivot Long Sell Low Dec 12, 2025 - 2 days
RSI Long Pivot Signal Sell Low Oct 03, 2025 - 51 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT Y-MABS THERAPEUTICS INC.
Y-mAbs Therapeutics
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma. The company is also developin...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE